These are the posts from the Our Ideas section that have been tagged with Regulations.
To see all tags used in our posts, click here.
| 24th August 2016
In this article, Associate Consultant Louis Perdios talks about the immunotherapy drug Opdivo and the daunting challenges faced by BMS after disappointing results. However the future for Opdivo may not be as bleak as it seems.
| 7th March 2016
Not all organisations are in a position to look at maturity – for some, there’s still a pressing question that needs answering: Why does content need a strategy?
In this article, Content Marketing Manager Liz Inskip and guest blogger Adwoa Baah explain how having a documented strategy for content creation, distribution, management, and governance will empower your brand teams and create organisational efficiencies.
| 12th January 2016
Moving into 2016, we want to draw the focus to the issue of tangibly defining value in healthcare innovation and ensuring that the services that pharma and healthcare brands are developing are actually taken up and implemented. Managing Consultant James Atherton talks through some tangible tips for businesses and brands looking to surf the wave of disruption in 2016.
| 20th May 2015
In this blog, Senior Consultant Craig Moore, from the Blue Latitude Health Strategy team, discusses the application of the ABPI Code, including incorporating social media into digital patient services.
| 19th March 2015
Following on from our Top 7 Trends in Pharma Marketing for 2015 post, it is clear that the pharma marketing trends we expect to transform the healthcare sector are easier said than done.
Aurélie Pols from Mind Your Privacy has written this guest blog to talk about the first steps you need to take when considering data privacy and security.
| 16th June 2014
One of the challenges with pharma content marketing is how to increase the “indexability” of a web page, whilst adhering to the strict regulations we’re often bound by. Guest blogger Alec Cochrane discusses how to tackle this challenge.
| 17th February 2014
Customer data is collected and used by almost every marketing department globally to better target audiences, so is it now time to take the next step, and add DNA to the pharma marketing mix? Mark Assenti explores the ethical and scientific issues behind genetic marketing.
| 21st May 2013
There has been an increase in prominence of medical information within the healthcare communications mix in 2013. In this article, we dive a bit deeper into the three key trends driving this increase.